CRANFORD, N.J., Sept. 10, 2025 /PRNewswire/ – Citius Oncology, Inc. (“Citius Oncology”) (Nasdaq: CTOR), the oncology-focused subsidiary of Citius Pharmaceuticals, Inc. (“Citius Pharma”) (Nasdaq: CTXR), a late-stage biopharmaceutical company developing and commercializing first-in-class critical care products, announced the closing of its previously announced registered direct offering and concurrent private placement of an aggregate of 5,142,858 shares of common stock and unregistered warrants to purchase up to an aggregate of 5,142,858 shares of common stock. The combined effective offering price for each share of common stock and accompanying warrant was $1.75. The warrants have an exercise price of $1.84 per share, will be exercisable six months from the date of issuance, and will expire on the five and one-half year anniversary from the date of issuance.

Jericho, New York, Aug. 27, 2025 (GLOBE NEWSWIRE) – Curanex Pharmaceuticals Inc. (Nasdaq: CURX) (“Curanex” or the “Company”), a developmental stage pharmaceutical company focused on discovering and developing botanical drugs for inflammatory diseases, today announced the closing of its initial public offering (the “Offering”) of 3,750,000 shares of common stock at a public offering price of $4.00 per share, for gross proceeds of $15 million, before deducting underwriting discounts and offering expenses. The Offering was conducted on a firm commitment basis. The Company’s shares of common stock began trading on the Nasdaq Capital Market on August 26, 2025 under the ticker symbol “CURX.”

New York, June 26, 2025 (GLOBE NEWSWIRE) – Kandal M Venture Limited (Nasdaq: FMFC) (the “Company”), a contract manufacturer of affordable luxury leather goods with manufacturing operations in Cambodia, today announced the closing of its initial public offering (the “Offering”) of 2,000,000 Class A ordinary shares (the “Class A Ordinary Shares”) at a public offering price of $4.00 per share (the “Offering Price”). The Class A Ordinary Shares began trading on the Nasdaq Capital Market on June 25, 2025, under the symbol “FMFC.”

The Crone Law Group, P.C., led by Partner Liang Shih, acted as the U.S. Counsel to the underwriters for the offering.

In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 300,000 Class A Ordinary Shares at the Offering Price, less underwriting discounts.

The Offering was conducted on a firm commitment basis. Dominari Securities LLC acted as the representative of the underwriters, and Revere Securities LLC acted as the co-underwriter (collectively, the “Underwriters”) for the Offering.

About The Crone Law Group, P.C.

The Crone Law Group, P.C. is focused on corporate securities, securities compliance, and international business and trade, with significant experience working with domestic and foreign corporate issuers. The firm is unique in its ability to handle the most complex securities, M&A, corporate finance matters, intellectual property, and immigration law issues while providing clients with close, personal, service—not often available at larger, less intimate firms. We represent a select clientele that includes domestic and foreign publicly traded corporations, emerging companies, and entrepreneurs in various industries.

Meet our team members click here

To contact The Crone Law Group info@cronelawgroup.com

Hong Kong, April 08, 2025 (GLOBE NEWSWIRE) – TOP WIN INTERNATIONAL LIMITED (Nasdaq: TOPW) (the “Company” or “Top Win”), a Hong Kong-based wholesaler specializing in trading, distribution, and retail of luxury watches of international brands, announced the successful closing of its initial public offering (the “Offering”) of 2,664,000 ordinary shares (the “Ordinary Shares”) at the price of $4.00 per share (the “Offering Price”).

KUALA LUMPUR, April 3, 2025 (GLOBE NEWSWIRE) – WF Holding Limited (“WF Holding” or “Company”), a Malaysia-based manufacturer of fiberglass reinforced plastic (FRP) products, announced the successful closing of its initial public offering of 2,000,000 ordinary shares, par value $0.00005 per share (the “Ordinary Shares”), at a public offering price of $4.00 per share. The offering generated total gross proceeds of $8 million, before deducting underwriting discounts and other offering expenses. The Company’s Ordinary Shares started trading on the Nasdaq Capital Market on March 27, 2025 under the ticker symbol “WFF.”

VIRGINIA BEACH, VA, April 1, 2025 (ACCESS Newswire) – Inspire Veterinary Partners, Inc. (NASDAQ:IVP) (“Inspire” or the “Company”), an owner and provider of pet health care services throughout the U.S., today announced it has closed a securities purchase agreement with an investor to purchase 1,092,896 shares of its common stock (or pre-funded warrants in lieu thereof), Series A warrants to purchase 1,092,896 shares of common stock and Series B warrants to purchase 1,092,896 shares of common stock, pursuant to a registered direct offering for aggregate gross proceeds of approximately $2.0 million (the “Offering”).

VIRGINIA BEACH, VA, February 13, 2024 (ACCESSWIRE) — Inspire Veterinary Partners, Inc. (NASDAQ:IVP) (“Inspire” or the “Company”), an owner and provider of pet health care services throughout the U.S., today announced it has closed its previously announced public offering of shares of Class A common stock for gross proceeds of approximately $4.0 million, prior to deducting placement agent fees and other offering expenses payable by the Company. The Company intends to use the net proceeds from this offering for strategic acquisitions, the engagement of external, third-party marketing and business consultants, working capital and general corporate purposes. The Crone Law Group P.C. acted as counsel to Inspire. The offering was made only by means of a prospectus, copies of which may be obtained, when available, from: Spartan Capital Securities, LLC, 45 Broadway, New York, NY 10006, or by telephone at (212) 293-0123.

TAREN POINT, Australia, Feb. 10, 2025 (GLOBE NEWSWIRE) — Fitell Corporation (Nasdaq: FTEL) (“Fitell” or the “Company”), an online retailer of gym and fitness equipment in Australia, today announced the closing of its previously announced registered direct offering of 796,813 ordinary shares and an additional investment right to purchase up to 1,195,220 ordinary shares in the form of warrants, at a purchase price of $5.02 per ordinary share and associated warrant. The warrants have an exercise price of $5.02 per share, are exercisable immediately upon issuance and expire three years following the issuance date. The Crone Law Group, led by Liang Shih, acted as issuer counsel.

HONG KONG, Feb. 06, 2025 (GLOBE NEWSWIRE) – Plutus Financial Group Limited (“the “Company”) (NasdaqCM: PLUT), a Hong Kong-based financial services company, announced the closing of its initial public offering (the “Offering”) of 2,100,000 ordinary shares at a public offering price of $4 per ordinary share, for total gross proceeds of $8.4 million, before deducting underwriting discounts and offering expenses. The Offering was conducted on a firm commitment basis. The ordinary shares began trading on Nasdaq Capital Market under the ticker symbol “PLUT” on February 5, 2025.

Yantai, China, Jan. 23, 2025 (GLOBE NEWSWIRE) – Decent Holding Inc. (Nasdaq: DXST) (the “Company”), an established wastewater treatment services provider in China, today announced the closing of its initial public offering (the “Offering”) of 1,250,000 ordinary shares (the “Ordinary Shares”) at a public offering price of $4.00 per share. The Ordinary Shares commenced trading on Nasdaq Capital Market on January 22, 2025, under the ticker symbol “DXST”. The Offering closed on January 23, 2025.

Kowloon, Hong Kong, Jan. 23, 2025 (GLOBE NEWSWIRE) – CTRL Group Limited (the “Company”) (NasdaqCM: MCTR), an integrated marketing and advertising services provider in Hong Kong specializing in mobile games promotion for the local market, today announced the closing of its initial public offering (the “Offering”) of 2,000,000 ordinary shares at a public offering price of $4.00 per share. The ordinary shares began trading on Nasdaq Capital Market under the ticker symbol “MCTR” on January 22, 2025.

Ganzhou, China, November 21, 2024 (GLOBE NEWSWIRE) – The Crone Law Group, P.C. (“CLG”) acted as U.S. legal advisor to TMT Acquisition Corp (“TMT”) (Nasdaq: TMTCU, TMTC, and TMTCR), a publicly traded special purpose acquisition company that was acquired by eLong Power Holding Limited (“eLong”) (Nasdaq: ELPW). eLong Power is a provider of high-power battery technologies for commercial and specialty vehicles and energy storage systems. The de-SPAC transaction was valued at $450,000,000.

Ningde, China, Oct. 18, 2024 (GLOBE NEWSWIRE) – Oriental Rise Holdings Limited (“Oriental Rise” or the “Company”) (NasdaqCM: ORIS), an integrated supplier of tea products in mainland China, today announced the closing of its initial public offering (the “Offering”) of 1,750,000 ordinary shares at a public offering price of $4 per share. The ordinary shares began trading on Nasdaq Capital Market under the ticker symbol “ORIS” on October 17, 2024.

BEIJING, China, Sept. 06, 2024 (GLOBE NEWSWIRE) – Pheton Holdings Ltd (the “Company” or “Pheton”), a healthcare solution provider specializing in treatment planning systems for brachytherapy and other related products and services, today announced the closing of its initial public offering (the “Offering”) of 2,250,000 Class A ordinary shares at a public offering price of $4.00 per share, for total gross proceeds of $9 million, before deducting underwriting discounts and other related expenses.

New York, NY.  August 13, 2024 — Citius Pharmaceuticals, Inc. (“Citius Pharma” or the “Company”) (Nasdaq: CTXR), a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, today announced that it has completed the previously announced merger of its oncology subsidiary with TenX Keane Acquisition (“TenX”) (Nasdaq: TENK), a publicly traded special purpose acquisition company. The combined company will operate as Citius Oncology, Inc. (“Citius Oncology”) and began trading on the Nasdaq stock exchange under the ticker symbol CTOR, on August 13, 2024.

Meishan, Sichuan, China, Feb. 23, 2024 (GLOBE NEWSWIRE) – Wetouch Technology Inc. (Nasdaq: WETH ) (“Wetouch” or the “Company”), a Nevada company, through its wholly-owned subsidiary, engaged in the research, development, manufacturing, sales and servicing of projected capacitive touchscreens, announced today the closing of its previously announced underwritten public offering of 2,160,000 shares of common stock at a price to the public of $5.00 per share (the “Offering”). The gross proceeds to the Company from this Offering were $10.8 million, prior to deducting offering expenses, commissions and underwriting discounts. In addition, the Company granted the underwriters a 45-day option to purchase up to 324,000 additional shares of common stock at the public offering price per share, less commissions and underwriting discounts.